Randomized Phase II Trial of the Sequences of Anthracyline and Taxane in Locally Advanced Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Docetaxel (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- Acronyms NeoSAMBA
- 01 Sep 2016 Planned End Date changed from 1 Jun 2014 to 1 Dec 2016.
- 01 Sep 2016 Planned primary completion date changed from 1 Dec 2013 to 1 Sep 2016.
- 18 Mar 2013 Planned end date changed from 1 Feb 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.